Health Canada approves first generic version of Novo Nordisk's Ozempic
28/04/2026 21:57
April 28 (Reuters) - Health Canada has approved the first generic version of Danish drugmaker Novo Nordisk's NOVOb.CO blockbuster diabetes drug Ozempic made by Indian drugmaker Dr Reddy's Laboratories REDY.NS, its website showed on Tuesday. (Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Tasim Zahid) ((Padmanabhan.Ananthan@thomsonreuters.com;))
Recent news on Dr. Reddy's Laboratories
See all newsDr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption